borderline significantP = 0.03
In model 5, the results for mRNFL were attenuated and only borderline significant (model 5: difference = −0.14 microns, 95% CI = −0.28 to −0.01, P = 0.03).
In model 5, the results for mRNFL were attenuated and only borderline significant (model 5: difference = −0.14 microns, 95% CI = −0.28 to −0.01, P = 0.03).
An initial significant adverse association between statin use and thinner measures was attenuated after adjustment for BMI, systolic blood pressure, diabetes, and cardiovascular disease (although for mRNFL, the adverse association remained nominally significant).